Literature DB >> 19288469

Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.

Michael S Okun1, Hubert H Fernandez, Samuel S Wu, Lindsey Kirsch-Darrow, Dawn Bowers, Frank Bova, Michele Suelter, Charles E Jacobson, Xinping Wang, Clifford W Gordon, Pam Zeilman, Janet Romrell, Pam Martin, Herbert Ward, Ramon L Rodriguez, Kelly D Foote.   

Abstract

OBJECTIVE: Our aim was to compare in a prospective blinded study the cognitive and mood effects of subthalamic nucleus (STN) vs. globus pallidus interna (GPi) deep brain stimulation (DBS) in Parkinson disease.
METHODS: Fifty-two subjects were randomized to unilateral STN or GPi DBS. The co-primary outcome measures were the Visual Analog Mood Scale, and verbal fluency (semantic and letter) at 7 months post-DBS in the optimal setting compared to pre-DBS. At 7 months post-DBS, subjects were tested in four randomized/counterbalanced conditions (optimal, ventral, dorsal, and off DBS).
RESULTS: Forty-five subjects (23 GPi, 22 STN) completed the protocol. The study revealed no difference between STN and GPi DBS in the change of co-primary mood and cognitive outcomes pre- to post-DBS in the optimal setting (Hotelling's T(2) test: p = 0.16 and 0.08 respectively). Subjects in both targets were less "happy", less "energetic" and more "confused" when stimulated ventrally. Comparison of the other 3 DBS conditions to pre-DBS showed a larger deterioration of letter verbal fluency in STN, especially when off DBS. There was no difference in UPDRS motor improvement between targets.
INTERPRETATION: There were no significant differences in the co-primary outcome measures (mood and cognition) between STN and GPi in the optimal DBS state. Adverse mood effects occurred ventrally in both targets. A worsening of letter verbal fluency was seen in STN. The persistence of deterioration in verbal fluency in the off STN DBS state was suggestive of a surgical rather than a stimulation-induced effect. Similar motor improvement were observed with both STN and GPi DBS.

Entities:  

Mesh:

Year:  2009        PMID: 19288469      PMCID: PMC2692580          DOI: 10.1002/ana.21596

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  40 in total

1.  Explosive-aggressive behavior related to bilateral subthalamic stimulation.

Authors:  M Sensi; R Eleopra; M A Cavallo; E Sette; P Milani; R Quatrale; J G Capone; V Tugnoli; M R Tola; E Granieri; P G Data
Journal:  Parkinsonism Relat Disord       Date:  2004-06       Impact factor: 4.891

2.  Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease.

Authors:  Anthony E Lang; José A Obeso
Journal:  Ann Neurol       Date:  2004-06       Impact factor: 10.422

Review 3.  Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications.

Authors:  Atchar Sudhyadhom; Frank J Bova; Kelly D Foote; Christian A Rosado; Lindsey Kirsch-Darrow; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

4.  Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation.

Authors:  Alexandre Berney; Michel Panisset; Abbas F Sadikot; Alain Ptito; Alain Dagher; Maria Fraraccio; Ghislaine Savard; Marc Pell; Chawki Benkelfat
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

5.  Lateralization of dementia of depression in stroke patients.

Authors:  K Bolla-Wilson; R G Robinson; S E Starkstein; J Boston; T R Price
Journal:  Am J Psychiatry       Date:  1989-05       Impact factor: 18.112

6.  Cerebral lateralization in depression.

Authors:  S E Starkstein; R G Robinson
Journal:  Am J Psychiatry       Date:  1986-12       Impact factor: 18.112

7.  Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease.

Authors:  Aurélie Funkiewiez; Claire Ardouin; Roshan Cools; Paul Krack; Valérie Fraix; Alina Batir; Stephan Chabardès; Alim-Louis Benabid; Trevor W Robbins; Pierre Pollak
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

8.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

9.  Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease.

Authors:  Johannes C Rothlind; Randall W Cockshott; Philip A Starr; William J Marks
Journal:  J Int Neuropsychol Soc       Date:  2007-01       Impact factor: 2.892

10.  Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease.

Authors:  A Funkiewiez; C Ardouin; E Caputo; P Krack; V Fraix; H Klinger; S Chabardes; K Foote; A-L Benabid; P Pollak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

View more
  173 in total

1.  Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort.

Authors:  Maren C Locke; Samuel S Wu; Kelly D Foote; Marco Sassi; Charles E Jacobson; Ramon L Rodriguez; Hubert H Fernandez; Michael S Okun
Journal:  Neurosurgery       Date:  2011-05       Impact factor: 4.654

Review 2.  [Deep brain stimulation for Parkinson's disease].

Authors:  J Herzog; G Deuschl
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

3.  The effect of cortical repetitive transcranial magnetic stimulation on cognitive event-related potentials recorded in the subthalamic nucleus.

Authors:  M Baláz; H Srovnalová; I Rektorová; I Rektor
Journal:  Exp Brain Res       Date:  2010-04-09       Impact factor: 1.972

Review 4.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

5.  Site of deep brain stimulation and jaw velocity in Parkinson disease.

Authors:  Lee T Robertson; Rebecca J St George; Patricia Carlson-Kuhta; Penelope Hogarth; Kim J Burchiel; Fay B Horak
Journal:  J Neurosurg       Date:  2011-08-12       Impact factor: 5.115

6.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 7.  Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease.

Authors:  Leonardo Almeida; Wissam Deeb; Chauncey Spears; Enrico Opri; Rene Molina; Daniel Martinez-Ramirez; Aysegul Gunduz; Christopher W Hess; Michael S Okun
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

8.  STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice.

Authors:  Nolan R Williams; Kelly D Foote; Michael S Okun
Journal:  Mov Disord Clin Pract       Date:  2014-04-01

Review 9.  The role of the subthalamic nucleus in cognition.

Authors:  David B Weintraub; Kareem A Zaghloul
Journal:  Rev Neurosci       Date:  2013       Impact factor: 4.353

Review 10.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.